Booz Allen Hamilton (BAH) Tops Q3 EPS by 5c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/27/2026
- Nasdaq futures outperform after Nvidia puts AI fears to rest
- Nvidia forecasts 70% sales growth next year, signals AI spending boom has years left to run
- Oil gains as traders weigh prospects of easing Middle East supply disruptions
- Could SpaceX's orbital compute avoid the political headwinds facing data centers?
- Could Meta's teen settlement be less painful than feared? Citi weighs in
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- Boston Scientific discloses cybersecurity incident causing global disruption
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- Wall Street stocks end tad lower after hot inflation data ahead of Nvidia earnings
- FDA approves Revolution Medicines pancreatic cancer drug Rasonque
Booz Allen Hamilton (BAH) PT Raised to $46 at Credit Suisse
February 7, 2018 7:53 AM ESTCredit Suisse raised its price target on Booz Allen Hamilton (NYSE: BAH) to $46.00 (from $42.00) while maintaining a Outperform rating.
The firm raises 2018/2019/2020 EPS estimates to $1.97/$2.32/$2.64
... MoreBooz Allen Hamilton (BAH) PT Raised to $47 at Vertical Research Partners; 'Upside case is clear'
February 6, 2018 8:46 AM ESTVertical Research Partners raised its price target on Booz Allen Hamilton (NYSE: BAH) to $47.00 (from $43.00) while maintaining a Buy rating.
Adjusting for the new tax rate, the firm's Adjusted EPS goes from $1.91 to $1.96 for FY18, and $1.95 to $2.34 for FY19. FY18 FCF... More
